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Abstract
Introduction and objective. The growing epidemic of childhood obesity has forced scientists to search for methods to 
prevent feeding disorders. Increasing interest in appetite regulating hormones has revealed their influence on energy 
homeostasis after birth or even in utero.   
State of knowledge. The presence of ghrelin in the stomach of human foetuses and the distinctive production in the 
pancreas of neonates suggests the role of ghrelin in pre- and post-natal development. The neonatal period appears to be 
a critical time for the formation of adipose tissue-hypothalamus circuits, thus the amount of adipocytes in foetal life may 
be a major regulator of food intake. Insulin’s orexigenic effect in the arcuate nucleus of the hypothalamus can be a major 
modulator of foetal development.   
Objective. This review, based on available literature, aims to analyses the role of appetite regulating hormones in foetal 
development.   
Summary. Different concentrations of hormones, such as ghrelin, leptin and insulin during foetal life raises the question 
whether or not they can be modulated, thereby avoiding obesity before birth. Children with pancreas agenesis showed 
smaller body size at birth, which emphasises the probable role of insulin in foetal growth. Study of sheep foetuses with 
IUGR confirmed these finding. Appetite-regulating hormones show different roles in foetal development and seem to be 
essential in the perinatal period.
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INTRODUCTION
The growing epidemic of childhood obesity has forced 
scientists to search for prevention methods that could affect 
the regulation of energy homeostasis during foetal life and 
lead to early avoidance of feeding disorders. The increasing 
popularity of appetite regulating hormones has revealed 
their influence on energy homeostasis at birth or even in 
utero [1, 2, 3], which suggests they can play a role in the 
regulation of foetal development [4, 5, 6]. After Barker noticed 
in 1998 that newborns with low birth weight were more likely 
to have heart disease or diabetes in adulthood, scientists 
began searching for an answer to the question whether or 
not the factors which predispose newborns to reach too 
low or too high birth weight could be modulated to prevent 
diseases such as obesity and diabetes. Barker’s theory of foetal 
programming highlights the influence of the mother’s lifestyle 
during pregnancy on the birth weight and susceptibility to 
diseases. Another study by Barker and Hale confirmed the 
‘thrifty phenotype’ hypothesis: maternal under-nutrition 
during pregnancy can affect foetal metabolism [7]. There 
is some speculation about energy homeostasis regulating 
hormones modulating feeding behaviours directly after birth 
[8, 9]. All peripheral signals about the energy status reach the 
centre for hunger and satiety regulation – the hypothalamus 
[10]. Arcuate nucleus (Arc), paraventricular nucleus (PVN) 
lateral hypothalamic area (LHA) and the perifornical area 
(PFA) are structures in the hypothalamus involved in the 
regulation of energy homeostasis by communication with 
nucleus of the solitary tract (NTS), resulting in termination 
or initiation of feeding. The vagal nerve is also involved in 
transmission of peripheral signals concerning nutritional 
status [11].
Ghrelin – hypothalamic regulation of energy homeostasis. 
Ghrelin was discovered in 1999 by Kojima et al. and many 
studies have confirmed its additional roles beside the 
orexigenic effect [12]. It was discovered as a new endogenous 
ligand for the growth hormone secretagogue(GHS) receptor. 
Ghrelin modulates GH secretion by GHS-R 1a receptor, 
different from somatoliberin and somatostatin(main 
controllers of GH secretion). When ghrelin binds to 
GHS-R 1a, phospholipase C is activated, phopshoinosytol 
concentration rises and protein kinase C is activated, 
resulting in the release of calcium ions from the endoplasmic 
reticulum. Activation of kinase C stimulates GH secretion 
[1, 13]. Beside its direct effect, ghrelin stimulates GH secretion 
by modulating the expression of Pit-1 transcription factor 
in the anterior pituitary gland. Ghrelin’s indirect effect on 
GH secretion is realised by an increased expression of GH 
gene in somatotroph cells [13, 14, 15]. Researchers confirmed 
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the time- and dose-dependent effect of ghrelin activation of 
Pit-1 in GH cells cultures. The regulation of growth hormone 
secretion, both direct and indirect, is independent of the 
ghrelin orexygenic role in the hypothalamus [16].
The largest number of ghrelin-producing cells in adults 
(X/A-like cells) are in the corpus gastricum and fundus 
gatricus. The synthesis of ghrelin, but in smaller quantities, 
also occurs around the hypothalamic arcuate nucleus 
[17, 18, 19, 20], pituitary gland [21], gut [22], cells of the 
immune system [23], lungs [21, 24, 25, 26], kidneys, gonads, 
placenta and pancreas [3, 21, 27]. Ghrelin produced in the 
stomach and nuclei of the hypothalamus plays the main role 
in regulating the body’s energy status [28].
The discovery of ghrelin receptor afferent neurons 
around the vagus nerve in an animal model gave rise to 
speculations that the hypothalamic effect is made possible 
by signals sent from the stomach through the nerve, rather 
than through a direct transfer of peripheral ghrelin to the 
hypothalamus [29]. Date et al. studied rats after vagotomy and 
their results confirmed reduction of the ghrelin orexygenic 
effect after the surgery [30]. Furthermore, subdiaphragmatic 
vagotomy caused complete elimination of hunger-induced 
increased ghrelin levels. Studies in humans confirmed this 
relationship. People after vagotomy treated with ghrelin did 
not show increased food intake [31]. Other studies indicate 
a lack of participation of the vagus nerve afferent fibres in 
the stimulation of food intake in response to peripheral 
ghrelin [32]. It is possible that there are some compensatory 
mechanisms which enable the communication of peripheral 
ghrelin with hypothalamic arcuate nucleus after vagotomy. 
Some studies suggest that only some of the ghrelin functions 
are implemented via the vagus nerve [33]. The food intake 
regulation mechanism is shown in Figure 1. The signal sent by 
ghrelin from the stomach reaches the nucleus of the solitary 
tract (NTS). The production of ghrelin in the hypothalamic 
arcuate nucleus area is probably also stimulated by the 
vagus nerve. Binding of ghrelin to its receptor around 
NPY/AgRP/GABA neurons increases the expression of 
genes encoding neuropeptide Y (NPY) and agouti-related 
protein (AgRP). NPY and AgRP inhibit the activity of 
anorexygenic neurons in the paraventricular nucleus (PVN), 
at the same time stimulating orexygenic neurons in the LHA. 
In addition, ghrelin causes an inhibition of POMC/CART 
neurons (stimulators of anorexygenic response) through γ 
– aminobutyric acid (GABA). This results in the orexygenic 
neurons sending signals to the NTS and generating a food-
seeking behaviour [21, 22, 35].
Leptin – anorexigenic factor in hyphothalamus. Leptin 
is produced by white adipose tissue, and in less quantity 
by the placenta, ovaries, testicles, stomach, pituitary gland, 
vascular endothelium, brown adipose tissue and skeletal 
muscle [8, 36]. Pleiotropic effects of leptin, both central and 
peripheral, are due to the multiple isoforms of the receptor, 
whose presence is confirmed not only in the hypothalamus. 
Studies have shown that leptin receptor (Ob-R) is present, 
among others, in the intestine, pancreas β cells, liver, skeletal 
muscle cells, pituitary, lymphocytes and monocytes, ovary, 
and endometrium, as well as in adipocytes [37, 38, 39]. 
However, the most important effect of leptin involves the 
control of body weight by acting on the hypothalamus. When 
leptin reaches hyphothalamus it binds to Ob-R around Arc 
(Figure 1). Receptor Ob-R is present around POMC/CART 
neurons (anorexigenic response) and AgRP/Npy/GABA 
neurons (responsible for orexigenic response). As a result 
of the stimulation of POMC/CART neurons by leptin, 
α-melanocortin is released which binds to its receptor 
(MC4-R) around PVN where anorexigenic neurons generate 
a fasting behaviour signal in NTS. POMC/CART neurons 
inhibit orexigenic neurons. Leptin suppresses expression 
of AgRP/NpY/GABA neurons whose products are released 
in periods of energy deficiency. As a consequence of all 
these actions, an anorexigenic signal arises and reaches 
NTS causing satiety [11, 35]. The effect of leptin on growth 
is also linked to its effects on GH secretion by inhibiting 
hypothalamic somatostatin production, and by direct effects 
on the pituitary somatotroph cells [11, 40].
Hypothalamic action of insulin. Hypothalamic action of 
insulin in the control of energy homeostasis is one of the most 
significant roles of this hormone. Insulin diffuses directly 
around Arc and binds to its receptor located on POMC/CART 
neurons and AgRP/NpY/GABA neurons. POMC/CART 
neurons, through enhanced release of α-melanocortin, 
stimulate anorexigenic neurons. In addition, insulin increases 
the inhibitory effect of POMC/CART neurons on orexigenic 
neurons. Binding insulin to AgRP/NpY/GABA neurons 
stimulates release of AgRP and NpY, the role of which is to 
actuate orexigenic neurons and inhibit anorexigenic neurons. 
The result of insulin action in the area of Arc is a signal sent 
from the stimulated anorexigenic neurons to the NTS, which 
causes satiety [11, 35].
Figure 1. Regulation of food intake at the level of arcuate nucleus in the 
hypothalamus. Orexigenic effect of ghrelin, anorexigenic effect of leptin and 
insulin through stimulation or inhibition of neurotransmitters secretion resulting 
in food seeking or fasting behaviour.
Adapted from: [34]
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Presence of ghrelin in human foetuses. Ghrelin was found 
for the first time in the human foetal circulation by Cortelazzi 
et al. In this study, 25 samples of foetal blood between 
20–39 weeks of gestation were analysed. From all foetuses, 
nine had IUGR (Intrauterine Growthe Restriction), while 
the weight of the other 16 was appropriate for gestational 
age. Ghrelin was detected in all examined samples of blood 
from foetuses in various periods of gestation. No gender 
differences were found in neonatal ghrelin concentrations 
[41]. Other studies suggested the placental origin of ghrelin 
in foetus. Despite these findings, ghrelin was not present in 
placental cells during the last trimester of pregnancy, thus 
it was considered there are other sources of fetal ghrelin. 
Ghrelin gene expression and ghrelin concentration in foetal 
rat pancreas and stomach were compared in other studies. 
It was confirmed that the total amount of foetal ghrelin 
levels were higher in comparison to the amount in adults, 
both pregnant and non-pregnant. Higher gene expression 
of ghrelin in foetal pancreatic cells than in the stomach was 
confirmed, in contrast to adult rats, where the ghrelin gene 
expression was higher in the stomach. Ghrelin mRNA and 
total ghrelin concentration in pancreatic cells was six to seven 
times higher than the in cells of the stomach. The results of 
these studies suggest that the main source of ghrelin can 
be the foetal pancreas and emphasises its relationship with 
the development of this organ in utero [42]. To confirm the 
concept of the origin of ghrelin from the stomach of foetuses 
and newborns, two embryos, 38 foetuses in various stages 
of development, and 3 infants were examined. Samples were 
collected from the antrum and corpus. In the embryonic 
cells, no ghrelin-producing cells (P/D1) were found, but their 
presence was confirmed in the eleventh week of gestation in a 
significant quantity in the corpus of stomach (107.7 cells/mm2 
mucosal epithelium).
It was found that ghrelin levels were lower in the third 
trimester of pregnancy; this level then increased in newborns, 
compared to the level in foetuses. The number of ghrelin-
producing cells in foetuses (107.7 cells/mm2) was higher 
compared with the levels in healthy adults measured in 
another study (60 cells/mm2) [9]. Expression of ghrelin 
was also shown in foetal pituitary gland somatotropes 
between 18–37 weeks of gestation. Despite these findings, 
the hypothalamic pituitary axis is activated probably in the 
first week of the extra-uterine life [43].
Foetal leptin and growth of the foetus. The presence of 
leptin receptor Ob-R in the gastric mucosa, oesophagus and 
intestine cells between the 7th–9th week of gestation and 
identification of leptin mRNA in gastric mucosa suggest the 
possible role of leptin in the development of the neonatal 
gastrointestinal tract. Leptin added to cultures of cells of the 
digestive tract, from 11-week-old fetuses, affects the DNA 
synthesis and consequently may increase the efficiency of 
the leptin receptor [44]. Beside effects on the gastrointestinal 
tract development in utero, leptin is probably also involved 
in the development of the brain, as in patients with genetic 
mutation, resulting in leptin deficiency, treated by leptin 
injections, in whom an increased brain mass concentration 
was shown [45]. Similar results were obtained by examining 
cells from mouse embryos, with the same defect in 16th–18th 
week of foetal life. The addition of leptin resulted in the 
growth of neuroepithelium cells [46]. Disrupted formation 
of pathways between Arc and PVA or LHA can be associated 
with abnormal brain apprising the the body’s energy status. 
In leptin deficient (ob/ob) mice, the neuronal pathways 
from Arc are permanently disrupted and leptin treatment 
in adulthood did not reverse this defect. Interestingly, 
the intervention in newborns led to the reconstruction of 
pathways between Arc and other parts of the hypothalamus, 
and mice growth showed no obesity [47]. The appearance 
of leptin between the 6th–10th week of gestation with the 
beginning of lipidogenesis raises the claim that it may have 
a part in the formation of adipose tissue: the neonatal period 
is considered to be a critical time for formation of brain-
pituitary adipose tissue axis. Neonatal leptin may be an 
initiator and modulator of hypothalamic arcuate nucleus 
response [48].
Insulin role in foetal growth. The presence of foetal insulin in 
the 8th week of gestation was confirmed. Foetal pancreas is the 
source of insulin as the transfer of maternal insulin through 
placenta is not possible. Study of children with pancreas 
agenesis confirmed the role of insulin in foetal growth as they 
showed smaller body size at birth. Undoubtedly, the degree of 
foetal nutrition depends on the amount of nutrients supplied 
by the mother and her metabolic status [49]. According to 
the Pedersen’s theory about foetal macrosomia in diabetic 
mothers, it is connected with an excessive amount of glucose 
penetration to the foetus, resulting in high levels of insulin 
in the foetus and thus increased growth [50]. The insufficient 
amount of glucose delivered to the foetus can result in very 
low birth weight. This mechanism involves a compensatory 
increase of gluconeogenesis, leading to the growth restriction 
because of insufficient amount of essential amino acids. 
Another study of sheep foetuses with IUGR showed a reduced 
by 76% of pancreatic β-cell mass in the perinatal period due 
to reduced proliferation of these cells during the development 
of the foetus [51].
CONCLUSIONS
Appetite-regulating hormones, besides their hypothalamic 
action, may have an influence on foetal growth. Ghrelin 
is involved in the differentiation and proliferation of 
somatotrophes, which confirms its impact on growth and 
development. The presence of ghrelin and its receptor in 
various cells and organs shows its broad activity in the 
body. The total amount of foetal ghrelin levels are higher 
in comparison to the amount in adults, which affirms its 
importance in prenatal life. Identification of leptin mRNA 
in the gastric mucosa of the foetus suggests a possible role 
of leptin in the development of the neonatal gastrointestinal 
tract. Leptin is probably involved in the development of the 
brain and pathways between arcuate nucleus and other parts 
of hypothalamus. Children with pancreas agenesis showed 
smaller body size at birth, which emphasises the probable 
role of insulin in foetal growth. A study of sheep foetuses 
with IUGR confirmed these finding. Appetite regulating 
hormones showed different roles in foetal development 
and seem to be essential in the perinatal period. Different 
concentrations of this hormones during foetal life raises a 
question about whether or not they can be modulated and 
thereby avoid obesity before birth.
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